Browse Topic
Infectious Diseases
-
April 01, 2022Lessons from the ‘long COVID’ clinic
Doctors who treat long COVID are trying to understand the mysterious syndrome that can follow infections, such as why some patients with mild illness experience ongoing breathing problems and why some with severe disease end up with no lung scarring.
Read More
-
February 04, 2022Por qué MIS-C es una complicación de COVID potencialmente fatal que los padres no dejarían de notar
El Síndrome Inflamatorio Multisistémico en Niños (MIS-C) generalmente ocurre cuando muchas familias menos lo esperan – después de que un niño se ha recuperado de una infección de COVID-19. Dean Blumberg, jefe de enfermedades pediátricas infecciosas en el Hospital de Niños de UC Davis, responde a preguntas comunes sobre esta complicación potencialmente fatal.
Read More -
February 02, 2022
Why MIS-C is a life-threatening COVID-19 complication that parents don’t want to miss (video)
Multisystem Inflammatory Syndrome in Children (MIS-C) often strikes when many families least expect it – after a child has recovered from COVID-19 infection. Dean Blumberg, chief of pediatric infectious diseases at UC Davis Children’s Hospital, answers common questions about this life-threatening complication.
Read More
-
January 25, 2022Pfizer’s new COVID antiviral pill Paxlovid now available for limited use
UC Davis Medical Center is now using Pfizer’s new COVID antiviral pill Paxlovid in patients at high risk of COVID complications. The pill, which can be taken at home, has been shown to dramatically decrease the risk of hospitalization and death.
Read More -
January 14, 2022Which mask protects best against the Omicron variant?
With the highly contagious COVID-19 Omicron variant surging, many people are reconsidering the type of mask they wear. A UC Davis Health infectious diseases expert has advice about when to wear cloth, surgical, N95 or KN95 masks.
Read More
-
December 22, 2021Upcoming webinar discusses effects of COVID-19 on African American/Black population
UC Davis Health pediatrician Michael Lucien and social justice leader Denisha “Coco” Bland will host a free webinar via Zoom to discuss the effects of COVID-19 on African American and Black populations and offer strategies and solutions to help.
Read More -
December 01, 2021New study shows vaccinated health care workers at low risk of transmitting COVID-19
A new study by infectious disease experts Sarah Waldman and Stuart Cohen shows vaccinated health care workers with breakthrough COVID-19 infections are at a low risk of transmitting the virus to patients and colleagues in a healthcare setting. Infection prevention strategies were key.
Read More
-
November 18, 2021Health experts answer questions about COVID-19 and vaccines in kids ages 5 to 11
Dean Blumberg, chief of pediatric infectious diseases at UC Davis Children’s Hospital, and general pediatrician Rachel Heidt, will be participating in a virtual Q&A session, “COVID-19 and Vaccines for Children 5-11 years old,” on Thursday, Dec. 2 from 5:30-6:30 p.m.
Read More -
November 15, 2021
Your top COVID-19 questions, answered by White House Chief Science Officer David Kessler
David Kessler, the chief science officer and leader in COVID-19 efforts, provided insights on the rise of mental health issues, COVID vaccines for kids, booster shots, the new oral antiviral drugs, and the rare vaccine side effects.
Read More -
November 15, 2021New study shows UC System mitigation efforts reduced campus COVID-19 infection rates
A new study shows that mitigation efforts to reduce COVID-19 on the 10 University of California campuses during the fall of 2020 minimized campus transmission and outbreaks and limited spread to surrounding communities.
Read More -
November 08, 2021Experts say monoclonal antibody treatment is not a substitute for COVID-19 vaccines
Monoclonal antibody treatments have been shown to reduce COVID-19-related hospitalization or deaths in high-risk patients. But UC Davis Health infectious disease experts explain why they’re not a replacement for the COVID-19 vaccine.
Read More -
November 02, 2021What to know about Merck's COVID-19 treatment pill
UC Davis Health infectious diseases specialist George Thompson answered some commonly asked questions about Merck’s new COVID-19 pill. The medication could be given in the days after COVID-19 symptoms arise to prevent severe disease.
Read More
-
October 29, 2021Drought raises concern about elevated risks of Valley fever
UC Davis Health infectious disease experts are concerned the drought in California could lead to an increase in cases of Valley fever, a disease that primarily presents as a respiratory illness.
Read More
-
August 19, 2021How to protect yourself from smoky air due to the Caldor, Dixie wildfires
Poor air quality caused by wildfire smoke can affect lung health, particularly for those with asthma and other respiratory conditions. UC Davis Health experts have some tips for protecting yourself when it’s smoky outside.
Read More -
August 04, 20219 things to know about COVID-19 and the Delta variant as kids return to school (video)
The Sacramento area is seeing more cases of COVID-19 and the highly contagious Delta variant. What does this mean for students who are slated to be back on campus, especially those too young to be vaccinated?
Read More
-
June 24, 2021Study confirms the low likelihood that SARS-CoV-2 on hospital surfaces is infectious
A new study confirms the low likelihood that coronavirus contamination on hospital surfaces is infectious. The study is the original report on recovering near-complete SARS-CoV-2 genome sequences directly from surface swabs.
Read More -
June 24, 2021New COVID-19 vaccine clinic for people with autism, other neurodevelopmental conditions (video)
The UC Davis MIND Institute is offering a COVID-19 vaccine clinic for individuals with autism and other neurodevelopmental conditions. The clinic will offer a comfortable experience for families, including sensory support and specially trained staff.
Read More
-
May 07, 2021UC Davis Health now enrolling children ages 12-17 for Novavax coronavirus vaccine trial
UC Davis Health will soon launch a stage 3 clinical trial for a new coronavirus vaccine for children ages 12-17 with the National Institutes of Health (NIH) and Novavax. The two-year study aims to enroll 100 participants.
Read More
-
January 28, 2021Twelve COVID-19 treatments being tested at UC Davis School of Medicine
In the search for potential COVID-19 treatments, UC Davis School of Medicine is recruiting participants for more than 12 clinical trials.
Read More -
January 13, 2021New, more contagious strains of COVID-19 may be spreading quickly
Natural mutations of the coronavirus have created two fast-spreading COVID-19 variants. Infectious disease expert Dean Blumberg explains why they are more contagious, how they may affect people, and how we can protect ourselves.
Read More